Company: CRNX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-029050
Chunk: 86

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 14
Chunk 86
---
 and administrative expenses

        (99,737
        )

        (58,094
        )

        (42,394
        )

        Total other income, net

        40,916

        13,277

        4,974

        Loss on equity method investment

        (470
        )

        (5,198
        )

        (1,010
        )

        Segment and consolidated net loss
         
        $
        (298,408
        )
         
        $
        (214,529
        )
         
        $
        (163,918
        )
       
      (1) Other research and development are comprised of non-personnel related research and development indirect costs incurred for the benefit of multiple research and development programs, including depreciation, and other facility-based expenses, such as rent expense.

F-29

14. EMPLOYEE SAVINGS PLANThe Company has a defined contribution 401(k) benefit plan (the “401(k) Plan”) for all eligible employees, effective May 1, 2016. The plan permits participants to contribute up to the amount allowable under federal limits of annual pre-tax compensation to the 401(k) Plan. Discretionary matching contributions to the 401(k) Plan are permitted in an amount equal to 50% of the first 6% of the employee’s taxable income up to a maximum of $3,000 per year. The Company accrued approximately $1.0 million, $0.7 million, and $0.5 million for matching contributions for the years ended December 31, 2024, 2023 and 2022, respectively.

F-30

EXHIBIT INDEX

    Exhibit

    Incorporated by Reference
      
    Filed

    Number
      
    Exhibit Description
     
    Form

    Date

    Number
     
    Herewith

    3.1
      
    Amended and Restated Certificate of Incorporation 
      
    8-K

    7/20/2018

    3.1

    3.2
      
    Amended and Restated Bylaws
      
    8-K

    12/12/2023

    3.1

    4.1
      
    Specimen Stock Certificate Evidencing the Shares of Common Stock
      
    S-1/A

    7/09/2018

    4.1

    4.2
     
    Description of Registered Securities